주식/증권
➡️ 중립
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth
요약
IRIDEX posts a narrower year-over-year net loss per share in Q1'26 as strong glaucoma product sales and lower operating costs helped offset weakness in retina sales and supply-chain disruptions.